Here's a headline that calls for celebration. 60% of Indians might just be a few months away from receiving the Covid-19 vaccine.
Splashing the cash
According to a global survey, India is the largest buyer of COVID-19 vaccines in the world with 1.6 billion doses. The nation has purchased huge amounts of doses from three candidates - Oxford University - Aztrazeneca vaccine, US based Novavax, and Sputnik V of Russia's Gamaleya Research Institute.
India is followed by the European Union and the US which has purchased close to a billion doses from six different candidates.
Playing the right cards.
India being one of the vaccine manufacturing countries, was able to come to favorable manufacturing and purchase agreements in advance. All the vaccines pre-booked by India are manufactured by Indian companies – Oxford-AstraZeneca and Novavax by Serum Institute of India (SII) in Pune and Sputnik V by Dr Reddy’s Lab in Hyderabad.
The numbers that count.
The 1.6 billion doses would cover 800 million people or 60 per cent of India’s population. This should be enough to develop herd immunity, a form of indirect protection from infectious disease that occurs when a sufficient percentage of a population has become immune to an infection.
The first 500 million doses would be given to 250 million people mostly comprising of frontline workers, healthcare workers, sanitation, emergency services, and security services.
Bottom line: A vaccine is on the brink of being approved and we can't wait to take our masks off.